The tumor cells were negative expression of CgA, CD56, CK5/6, CK20, Myogenin, MyoD1, Desmin, CEA, S100, CK8/18, CDX2, CD20, CD5, CD3, CD79a, LCA and HMB45. This evidence concerns the gene PMEL and neoplasm.